Cargando…
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Autor principal: | Sorscher, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515591/ https://www.ncbi.nlm.nih.gov/pubmed/31088529 http://dx.doi.org/10.1186/s13148-019-0667-4 |
Ejemplares similares
-
Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis
por: Sorscher, Steven
Publicado: (2023) -
Noninvasive prediction of response to cancer therapy using promoter profiling of circulating cell‐free DNA
por: Guo, Zhi‐Wei, et al.
Publicado: (2020) -
Clinical Trials in Oncology and Defining Benefit
por: Sorscher, Steven
Publicado: (2017) -
CHEK2 Pathogenic Germline Variants in Patients With NSCLC
por: Sorscher, Steven
Publicado: (2022) -
Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)